# The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts.

> **NCT04400760** · PHASE2,PHASE3 · COMPLETED · sponsor: **The University of The West Indies** · enrollment: 40 (actual)

## Conditions studied

- Platelet Dysfunction

## Interventions

- **DRUG:** DAPA Tx

## Key facts

- **NCT ID:** NCT04400760
- **Lead sponsor:** The University of The West Indies
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04400760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04400760, "The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts.". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04400760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*